Management of Multiple Myeloma
Clinical Updates from ASH2020
March 20th , 2021
7:30 am -10:15 am PST
Held Virtually on Zoom
This educational activity is free to attend for all healthcare providers. However, employees of ACCME defined ineligible entity (formerly – commercial interests) must register as “Industry” and pay a fee to attend this meeting even if they are licensed healthcare providers.
This CME-accredited activity “Management of multiple myeloma: clinical updates from ASH2020 Annual Meeting”, is a live-streamed webcast and enduring activity featuring leading experts in the field of multiple myeloma who will provide a comprehensive overview of noteworthy data presented at the 62nd American Society of Hematology Annual Meeting in December of 2020. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in multiple myeloma treatment. Expert faculty will place abstract findings into clinical context and discuss how the results may change the current standard of care. This meeting allows those who seek a concise critical review, the opportunity to hear expert faculty review and place in context the highlights from the ASH2020 annual meeting, in a two-hour program.
Upon successful completion of this educational activity, participants will be able to:
- Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of multiple myeloma
- Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact multiple myeloma management
- Integrate emerging evidence into treatment paradigms for the treatment of multiple myeloma
Dr. Siddhartha Yadav
Mayo Cancer Clinic
- Innovative and integrated learning environment
- Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement
- Livestream delivery method allows ample opportunities to network with colleagues and interact with faculties; enduring materials allow learners opportunities to learn at their convenience.
- Program topics can immediately be applied to clinical practice.
CME Credit Statement
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 2.0 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.0 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.